Watson, R., & Fairfax, B. (2023). Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer.
Chicago-viite (17. p.)Watson, RA, ja B. Fairfax. Characterising CD8+ T Cell Transcriptomic and Clonal Consequences of Immune Checkpoint Blockade for the Treatment of Cancer. 2023.
MLA-viite (9. p.)Watson, RA, ja B. Fairfax. Characterising CD8+ T Cell Transcriptomic and Clonal Consequences of Immune Checkpoint Blockade for the Treatment of Cancer. 2023.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.